Yi Xue

461 total citations
24 papers, 348 citations indexed

About

Yi Xue is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Xue has authored 24 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Xue's work include S100 Proteins and Annexins (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Occupational and environmental lung diseases (4 papers). Yi Xue is often cited by papers focused on S100 Proteins and Annexins (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Occupational and environmental lung diseases (4 papers). Yi Xue collaborates with scholars based in China, United States and Taiwan. Yi Xue's co-authors include Weidong Zhu, Rihua Zhang, Yun Liu, Xuemin Gao, Hong Xu, Shifeng Li, Dingjie Xu, Wenchen Cai, Menglan Liu and Qiong Huang and has published in prestigious journals such as Advanced Functional Materials, ACS Applied Materials & Interfaces and Experimental Cell Research.

In The Last Decade

Yi Xue

21 papers receiving 346 citations

Peers

Yi Xue
Yi Xue
Citations per year, relative to Yi Xue Yi Xue (= 1×) peers Isabelle Laverdière

Countries citing papers authored by Yi Xue

Since Specialization
Citations

This map shows the geographic impact of Yi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xue more than expected).

Fields of papers citing papers by Yi Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xue. The network helps show where Yi Xue may publish in the future.

Co-authorship network of co-authors of Yi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xue. A scholar is included among the top collaborators of Yi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xue. Yi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Yi, Cheng Yao, Liqian Zhao, et al.. (2025). Carrier-free Nano-Tetrandrine (PURE-T) for Psoriasis Treatment: Significant Therapeutic Efficacy and Its Regulatory Mechanism on Stratum Corneum Inflammation. ACS Applied Materials & Interfaces. 17(36). 50490–50504.
2.
Li, Xueyan, Lang Bai, Yi Xue, et al.. (2024). Acetyl-11-keto-β-boswellic acid restrains the progression of synovitis in osteoarthritis via the Nrf2/HO-1 pathway. Acta Biochimica et Biophysica Sinica. 56(11). 1644–1658. 4 indexed citations
3.
Wang, Jie, Yi Xue, Shuwei Yu, et al.. (2024). Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin. Pediatric Research. 95(6). 1543–1552. 10 indexed citations
4.
Huang, Shupei, Xinya Wang, Yi Xue, & Xinzhi Zhang. (2024). CEOS’ climate risk perception bias and corporate debt structure. Journal of International Money and Finance. 151. 103254–103254. 7 indexed citations
5.
Xue, Yi, Zhen Wu, & Xue Kang. (2024). Crystal structure of the Rib domain of the cell-wall-anchored surface protein from Limosilactobacillus reuteri. Acta Crystallographica Section F Structural Biology Communications. 80(9). 228–233.
6.
Xue, Yi, Zhen Wu, & Xue Kang. (2024). Crystal structure of the long Rib domain of the LPXTG-anchored surface protein from Limosilactobacillus reuteri. Acta Crystallographica Section F Structural Biology Communications. 80(5). 92–97. 1 indexed citations
7.
Jin, Fuyu, Dingjie Xu, Yaqian Li, et al.. (2021). Ac-SDKP Attenuates Activation of Lung Macrophages and Bone Osteoclasts in Rats Exposed to Silica by Inhibition of TLR4 and RANKL Signaling Pathways. Journal of Inflammation Research. Volume 14. 1647–1660. 18 indexed citations
8.
Gao, Xuemin, Hong Xu, Dingjie Xu, et al.. (2020). MiR-411–3p alleviates Silica-induced pulmonary fibrosis by regulating Smurf2/TGF-β signaling. Experimental Cell Research. 388(2). 111878–111878. 26 indexed citations
9.
Li, Shifeng, Dingjie Xu, Na Mao, et al.. (2020). Silica Perturbs Primary Cilia and Causes Myofibroblast Differentiation during Silicosis by Reduction of the KIF3A-Repressor GLI3 Complex. Theranostics. 10(4). 1719–1732. 14 indexed citations
10.
Gao, Xuemin, Dingjie Xu, Shumin Li, et al.. (2020). Pulmonary Silicosis Alters MicroRNA Expression in Rat Lung and miR-411-3p Exerts Anti-fibrotic Effects by Inhibiting MRTF-A/SRF Signaling. Molecular Therapy — Nucleic Acids. 20. 851–865. 36 indexed citations
11.
Wei, Zhongqiu, Hong Xu, Yi Xue, et al.. (2019). Rho GDP dissociation inhibitor α silencing attenuates silicosis by inhibiting RhoA/Rho kinase signalling. Experimental Cell Research. 380(2). 131–140. 13 indexed citations
12.
Zhang, Bonan, Hong Xu, Yi Xue, et al.. (2019). Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway. Toxicology Letters. 313. 30–41. 9 indexed citations
13.
Li, Shifeng, Hong Xu, Yi Xue, et al.. (2019). Ac-SDKP increases α-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-β1 and silica. Toxicology and Applied Pharmacology. 369. 17–29. 31 indexed citations
14.
Zhu, Weidong, Yi Xue, Chao Liang, et al.. (2016). S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer. Tumor Biology. 37(9). 12241–12250. 45 indexed citations
15.
Zhou, Wenbin, Hong Pan, Tiansong Xia, et al.. (2014). Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer. Journal of Biomedical Science. 21(1). 97–97. 45 indexed citations
16.
Zhang, Rihua, Dongming Su, Weidong Zhu, et al.. (2014). Estrogen suppresses adipogenesis by inhibiting S100A16 expression. Journal of Molecular Endocrinology. 52(3). 235–244. 18 indexed citations
17.
Li, Dong, Rihua Zhang, Weidong Zhu, et al.. (2013). S100A16 inhibits osteogenesis but stimulates adipogenesis. Molecular Biology Reports. 40(5). 3465–3473. 29 indexed citations
18.
Xue, Yi, et al.. (2013). [Effect of coenzyme Q10 on the expression of tumor necrosis factor-α and interleukin-10 in gingival tissue of experimental periodontitis in rats].. PubMed. 48(11). 660–3. 7 indexed citations
19.
Zhang, Rihua, Yi Xue, Li Dong, et al.. (2012). Insulin Glargine and Risk of Cancer: A Meta-Analysis. The International Journal of Biological Markers. 27(3). 241–246. 18 indexed citations
20.
Zhang, Rihua, Weidong Zhu, Xin Jing, et al.. (2011). S100A16 mediation of weight gain attenuation induced by dietary calcium. Metabolism. 61(2). 157–163. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026